在临床研究期间对医疗器械可用性的评估:对临床研究协议的范围审查
Laura Douze1,2, Jessica Schiro1,2, Louise Heyndels2
1Évaluation des technologies de santé et des pratiques médicales, University Lille, CHU Lille, ULR 2694 - METRICS, Lille, France.
Expert review of medical devices
|July 10, 2024
概括
将可用性研究整合到临床研究中是可行的,问卷提供了一种资源轻松的方法来评估用户满意度和易用性. 更多资源密集型的方法,如观察和采访,也可以用于全面的医疗器械评估.
科学领域:
- 医疗器械评估 医疗器械评估
- 人与计算机的互动.
- 临床研究方法论临床研究方法论
背景情况:
- 临床研究和可用性研究对于医疗器械评估至关重要,但在目标和方法上有很大的不同.
- 整合这些不同的研究类型在研究设计和执行方面提出了实际挑战.
研究的目的:
- 调查可用性研究如何在实践中融入临床研究.
- 在临床试验协议中分析可用性数据收集的方法和结果.
主要方法:
- 对clinicaltrials.gov数据库进行了系统的搜索.
- 确定和分析了包括可用性结果的临床研究协议.
主要成果:
- 分析了77个研究方案,确定了102个与可用性相关的结果.
- 满意度 (53/102) 和易用性 (33/102) 是最常被评估的结果.
- 调查问卷 (85/102) 是主要的数据收集方法,其次是采访 (24/102),观察 (9/102) 和日记 (6/102).
结论:
- 可用性数据收集可以有效地纳入临床研究,在不同的资源承诺.
- 使用问卷进行资源光集成,有效地捕捉用户的主观感知.
- 更多资源密集型的方法,如观察,采访和日记,适合特定的用户群体和环境,增强医疗器械的可用性评估.
相关概念视频
Clinical Trials
11.2K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
11.2K
Clinical Trials: Overview
5.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.5K
Preclinical Development: Overview
6.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
6.5K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
575
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
575
Bioavailability Study Design: Healthy Subjects Versus Patients
225
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
225
Clinically Relevant Drug Product Specifications: Methods of Establishment
285
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
285


